IBoutsider

IBoutsider | Joined since 2020-08-12

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

7

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
7
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2020-08-12 14:59 | Report Abuse

More than 100 vaccines are being developed around the world to stop the Covid-19 pandemic.according to WHO data. 

President Vladimir Putin rush to declare that Russia had become the first country in the world to grant regulatory approval to a Covid-19 vaccine to win the race, but they haven’t start mass producing the vaccine since it’s too hurry.

On the other side, the leading Sinopharm has already begun Final Phase III clinical trials of a COVID-19 vaccine in the United Arab Emirates since last month,and now launching another similar Final Phase III trials in Bahrain. with WHO(World Health Organization) doing the safety assessment.

Sinopharm has completed construction of a plant in Wuhan for mass production of a coronavirus vaccine, doubling its capacity to more than 200 million doses a year.

Sinopharm, which is developing the vaccine candidate at group laboratories in Wuhan and Beijing, also set up a factory with production capacity of 120 million doses in Beijing in April.

Stock

2020-08-12 14:47 | Report Abuse

Lol , we all know More than 100 vaccines are being developed around the world to stop the Covid-19 pandemic.according to WHO data. 

President Vladimir Putin rush to declare that Russia had become the first country in the world to grant regulatory approval to a Covid-19 vaccine to win the race, but they haven’t start mass producing the vaccine since it’s too hurry.

On the other side, the leading Sinopharm has already begun Final Phase III clinical trials of a COVID-19 vaccine in the United Arab Emirates since last month,and now launching another similar Final Phase III trials in Bahrain. with WHO(World Health Organization) doing the safety assessment.

Sinopharm has completed construction of a plant in Wuhan for mass production of a coronavirus vaccine, doubling its capacity to more than 200 million doses a year.

Sinopharm, which is developing the vaccine candidate at group laboratories in Wuhan and Beijing, also set up a factory with production capacity of 120 million doses in Beijing in April.

Stock

2020-08-12 14:34 | Report Abuse

Everyone knew More than 100 vaccines are being developed around the world to stop the Covid-19 pandemic.according to WHO data. 

President Vladimir Putin rush to declare that Russia had become the first country in the world to grant regulatory approval to a Covid-19 vaccine to win the race, but they haven’t start mass producing the vaccine since it’s too hurry.

On the other side, the leading Sinopharm has already begun Final Phase III clinical trials of a COVID-19 vaccine in the United Arab Emirates since last month,and now launching another similar Final Phase III trials in Bahrain. with WHO(World Health Organization) doing the safety assessment.

Sinopharm has completed construction of a plant in Wuhan for mass production of a coronavirus vaccine, doubling its capacity to more than 200 million doses a year.

Sinopharm, which is developing the vaccine candidate at group laboratories in Wuhan and Beijing, also set up a factory with production capacity of 120 million doses in Beijing in April.

Stock

2020-08-12 14:31 | Report Abuse

Everyone know More than 100 vaccines are being developed around the world to stop the Covid-19 pandemic.according to WHO data. 

President Vladimir Putin rush to declare that Russia had become the first country in the world to grant regulatory approval to a Covid-19 vaccine to win the race, but they haven’t start mass producing the vaccine since it’s too hurry.

On the other side, the leading Sinopharm has already begun Final Phase III clinical trials of a COVID-19 vaccine in the United Arab Emirates since last month,and now launching another similar Final Phase III trials in Bahrain. with WHO(World Health Organization) doing the safety assessment.

Sinopharm has completed construction of a plant in Wuhan for mass production of a coronavirus vaccine, doubling its capacity to more than 200 million doses a year.

Sinopharm, which is developing the vaccine candidate at group laboratories in Wuhan and Beijing, also set up a factory with production capacity of 120 million doses in Beijing in April.

Stock

2020-08-12 14:30 | Report Abuse

Everyone know More than 100 vaccines are being developed around the world to stop the Covid-19 pandemic.according to WHO data. 

President Vladimir Putin rush to declare that Russia had become the first country in the world to grant regulatory approval to a Covid-19 vaccine to win the race, but they haven’t start mass producing the vaccine since it’s too hurry.

On the other side, the leading Sinopharm has already begun Final Phase III clinical trials of a COVID-19 vaccine in the United Arab Emirates since last month,and now launching another similar Final Phase III trials in Bahrain. with WHO(World Health Organization) doing the safety assessment.

Sinopharm has completed construction of a plant in Wuhan for mass production of a coronavirus vaccine, doubling its capacity to more than 200 million doses a year.

Sinopharm, which is developing the vaccine candidate at group laboratories in Wuhan and Beijing, also set up a factory with production capacity of 120 million doses in Beijing in April.

Stock

2020-08-12 14:24 | Report Abuse

Since the given valuation target price for TiTijaya is lot higher after the collaboration with Sinopharm due to increased in possible income in healthcare sector. IB and large fund monopoly the price to collect at low. Due to limited fund, the process will end after slingshot theory rebounds and share price mostly go higher than previous.

Stock

2020-08-12 11:20 | Report Abuse

Join the ride, see the rebound
It’s the sling shot theory .
It’s a legal way of stock manipulation .

“If you can keep a good stock down, then you are able to load up for the ride back up. It's like a slingshot -- the harder you pull, the more propulsion you generate.

the company’s’ fundamentals will certainly take the stock higher, but hedge funds want to maximize the ride. Keeping a great stock down allows them to profit from quick predetermined trades rather than being fully invested all the time.